Oncology Data Advisor - Oncology and Hematology News for the Cancer Treatment Team

Skip to main content

Featured

Exploring Educational Opportunities During Hematology/Oncology Fellowship With Matthew Hadfield, DO, and Richa Thakur, MD

Exploring Educational Opportunities During Hematology/Oncology Fellowship With Matthew Hadfield, DO, and Richa Thakur, MD

In this Oncology Data Advisor Fellows Forum interview, Dr. Matthew Hadfield, Medical Oncology Fellow at Brown University, and Dr. Richa Thakur, Hematology/Oncology Fellow at Northwell Health, explore the different types of educational opportunities available during fellowship, including podcasts and in-person meetings, and strategies for finding the most up-to-date education. Visit https://i3health.com/new-cme/cme-meetings-for-institutions to explore the FREE live hematology/oncology meeting series offered by i3 Health, and book one for your institution today! Matthew Hadfield, DO: Hey,...

From the Editor's Desk

A Letter to Oncology Data Advisor Readers From Thomas Abrams, MD, Editor in Chief: Summer 2023

A Letter to Oncology Data Advisor Readers From Thomas Abrams, MD, Editor in Chief: Summer 2023

Hot enough for ya? While large swaths of the United States bake in an unrelenting summer heat wave, Oncology Data Advisor is having quite a summer hot streak of our own. We are honored to have received an APEX Award of Excellence for Health and Medical Websites. This is an extraordinary achievement that reflects the creativity and dedication of the OncData Editorial Board, who strive every day to bring the website's readership the most up-to-date and relevant opinions and information from the bl...

Expert Analysis

Enfortumab Vedotin Plus Pembrolizumab: Results of the EV-302 Trial With Thomas Powles, MD, MBBS, MRCP

Linvoseltamab for Relapsed/Refractory Multiple Myeloma: Results from IMS 2023 With Madhav Dhodapkar, MD

World Cancer Research Day With Samuel Kareff, MD, MPH; Maria Badillo, RN; Matthew Hadfield, DO; and Alankrita Taneja, MD

Twice Weekly, Biweekly, or Somewhere in Between? Updates on Dosing Schedules in Multiple Myeloma With Rahul Banerjee, MD, FACP, and Gurbakhash Kaur, MD

The Rise of Immunotherapy: Considerations to Ensure Optimal Management With Matthew Hadfield, DO

Melphalan for Liver-Directed Treatment of Uveal Melanoma With Richard Carvajal, MD

Practice Patterns

Confronting Knowledge Gaps in Rare Hematologic Malignancies

Confronting Knowledge Gaps in Rare Hematologic Malignancies

Enhanced Proficiency for Treatment Paradigms in Advanced Hepatocellular Carcinoma

Enhanced Proficiency for Treatment Paradigms in Advanced Hepatocellular Carcinoma

Assessing Proficiency in Squamous Non–Small Cell Lung Cancer Management

Assessing Proficiency in Squamous Non–Small Cell Lung Cancer Management

Noteworthy Headlines

Bosutinib Approved for Pediatric Patients With Chronic Myelogenous Leukemia

Bosutinib Approved for Pediatric Patients With Chronic Myelogenous Leukemia

Melphalan Approved for Liver-Directed Treatment for Uveal Melanoma

Melphalan Approved for Liver-Directed Treatment for Uveal Melanoma

Elranatamab-bcmm Granted Accelerated Approval for Multiple Myeloma

Elranatamab-bcmm Granted Accelerated Approval for Multiple Myeloma

Niraparib and Abiraterone Acetate Plus Prednisone Approved for BRCA-Mutated Metastatic CRPC

Niraparib and Abiraterone Acetate Plus Prednisone Approved for BRCA-Mutated Metastatic CRPC

$Talquetamab-tgvs Granted Accelerated Approval for Relapsed/Refractory Multiple Myeloma$

Talquetamab-tgvs Granted Accelerated Approval for Relapsed/Refractory Multiple Myeloma

Most Popular

Melphalan for Liver-Directed Treatment of Uveal Melanoma With Richard Carvajal, MD

Finding Your Why: Reflecting on the Passion Behind Oncology Nursing With Lauren Ghazal, PhD, FNP-BC

Take a Loved One to the Doctor Day With Beth Sandy, MSN, CRNP

World Cancer Research Day: How to Get Involved in Research With Waqas Haque, MD, MPH

The Rise of Immunotherapy: Considerations to Ensure Optimal Management With Matthew Hadfield, DO

Enfortumab Vedotin Plus Pembrolizumab: Results of the EV-302 Trial With Thomas Powles, MD, MBBS, MRCP

Twice Weekly, Biweekly, or Somewhere in Between? Updates on Dosing Schedules in Multiple Myeloma With Rahul Banerjee, MD, FACP, and Gurbakhash Kaur, MD

Podcast Spotlight

Melphalan for Liver-Directed Treatment of Uveal Melanoma With Richard Carvajal, MD

World Cancer Research Day: How to Get Involved in Research With Waqas Haque, MD, MPH

Pain Awareness Month With Nida Khan, MD, and Joseph Kalis, PharmD, BCOP

Prostate Cancer Awareness Month With Ulka Vaishampayan, MD

Raising Awareness of Prostate Cancer in Transgender Women With Farnoosh Nik-Ahd, MD, and Stephen Freedland, MD

Understanding the Tumor Microenvironment to Unlock the Key to Oncology Drug Development With Jesus Garcia, PhD

Appendix Cancer Awareness Month With Thomas Abrams, MD

National Immunization Awareness Month With Richa Thakur, MD, and Waqas Haque, MD

Investigating Epcoritamab for Follicular Lymphoma and Beyond With Reid Merryman, MD

Spotlighting Zolbetuximab for Gastric/Gastroesophageal Junction Adenocarcinoma with Kohei Shitara, MD